Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |